Feature Healthcare Stocks Top News A Close Look at Cardiol Therapeutics’ Phase 2 Results Shows the Path Forward Not all clinical trial results are cut and dried. Sometimes the outcome… Robin LeffertsDecember 9, 2025
Feature Healthcare Stocks Top News Investor Opportunity: Big Pharma Patent Cliff Spurring Surge in M&A Activity Here’s the short version: Big pharma is staring down a real patent… Robin LeffertsNovember 18, 2025
Feature Healthcare Stocks Top News Phase II Results Point the Way Forward for Cardiol Therapeutics For smaller public company drug developers clinical trial results are major catalytic… Robin LeffertsSeptember 16, 2025
Feature Healthcare Stocks Understanding the Importance of Left Ventricular Mass in Heart Conditions Left ventricular (LV) mass has emerged as one of the most powerful… Robin LeffertsSeptember 15, 2025
Feature Healthcare Stocks Top News Cardiol Therapeutics Announces Topline Results from the Phase II ARCHER Trial of CardiolRx™ in Acute Myocarditis Toronto, Ontario–(Newsfile Corp. – August 6, 2025) – Cardiol Therapeutics Inc. (NASDAQ: CRDL)… Ryan AllwayAugust 6, 2025
Feature Healthcare Stocks Former Eli Lilly CMO Joins Cardiol’s Board, Bolstering Drug Development, Clinical Trial, and Commercial Expertise As smaller clinical stage pharmaceutical companies advance drug candidates from the lab… Robin LeffertsMay 29, 2025
Feature Healthcare Stocks From $1 to $8? Why Analyst Experts Are Bullish on Cardiol Sometimes stock market performance doesn’t line up with the fundamentals of a… Robin LeffertsApril 1, 2025
Feature Healthcare Stocks Small Pharma, Big Gains: The Power of Clinical Trial Results For smaller pharmaceutical companies, valuation can be greatly impacted by progression in… Robin LeffertsMarch 13, 2025
Feature Healthcare Stocks These Healthcare Stocks Significantly Outperformed the Industry in 2024 While the stock market broadly experienced significant gains in 2024, a few… Robin LeffertsJanuary 27, 2025
Healthcare Stocks Cardiol Execs and Board Members Increase Equity, Signal Confidence Members of the Cardiol Therapeutics Inc. (Nasdaq: CRDL) (TSX: CRDL) executive team… Robin LeffertsDecember 23, 2024
